Aortic stiffness affects the coronary blood flow response to percutaneous coronary intervention

Michael C H Leung1, Ian T Meredith, James D Cameron

  • 1Cardiovascular Research Centre, Monash Medical Centre and Monash Univ., Melbourne, Victoria, Australia.

Insights

A stiff aorta is linked to reduced coronary blood flow (CBF) and a diminished response to percutaneous coronary intervention (PCI). This stiffness may limit the blood flow improvements achieved after successful PCI procedures.

Area of Science:

  • Cardiovascular Physiology
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Aortic mechanical properties, specifically stiffness, are hypothesized to influence coronary blood flow (CBF).
  • Existing human evidence on the impact of aortic stiffness on CBF and its response to percutaneous coronary intervention (PCI) is limited.
  • Animal studies present conflicting data regarding the relationship between aortic stiffness and coronary perfusion.

Purpose of the Study:

  • To investigate the association between aortic stiffness and coronary blood flow (CBF) before and after percutaneous coronary intervention (PCI).
  • To determine if aortic stiffness affects the CBF response to adenosine-induced hyperemia.
  • To evaluate the impact of aortic stiffness on the improvement of CBF following successful PCI.

Main Methods:

  • A prospective study involving 18 subjects undergoing elective PCI.
  • Coronary blood flow (CBF) was measured using a Doppler velocity guidewire before and after PCI.
  • Aortic mechanical properties were assessed by measuring central pulse-wave velocity (cPWV) and central pulse pressure (cPP).

Main Results:

  • A stiff aorta, indicated by higher cPWV, was inversely related to both resting and hyperemic CBF, independent of stenosis.
  • Hyperemic CBF response and the improvement in hyperemic CBF after PCI were less pronounced in individuals with a stiff aorta.
  • Successful PCI significantly improved coronary flow velocity reserve and fractional flow reserve in all subjects.

Conclusions:

  • Increased aortic stiffness is associated with reduced coronary blood flow (CBF).
  • A stiff aorta may attenuate the hyperemic CBF response and limit the benefits of successful PCI.
  • Aortic mechanical properties are a significant factor influencing coronary perfusion dynamics.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...